Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes

Summary

To evaluate the similarity of the efficacy and safety of semaglutide injection (QLG2065) vs. Ozempic® in patients with type 2 diabetes mellitus (T2DM) with poor blood glucose control after metformin treatment.

Timeline

Start

2023-07-10

Primary completion

2024-11-24

Completion

2025-01-22

Drugs

Indications